Loading...
Romosozumab for the treatment of osteoporosis
Romosozumab, a specific inhibitor of sclerostin, is a unique approach to therapy for postmenopausal osteoporosis and related disorders. The elucidation of sclerostin deficiency as the molecular defect of syndromes of high bone mass with normal quality, and the pivotal role of sclerostin as a mediato...
Saved in:
| Published in: | Osteoporos Sarcopenia |
|---|---|
| Main Author: | |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Korean Society of Osteoporosis
2018
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6362945/ https://ncbi.nlm.nih.gov/pubmed/30775535 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.afos.2018.03.002 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|